Send us Feedback

User contributions

Namespace:

(Newest | Oldest) View (Newer 50) (Older 50)

19:20, December 21, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Oxymorphone Brands)
20:56, September 29, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
20:55, September 29, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Capital for Clinical Trials and Acquisitions)
20:54, September 29, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
20:54, September 29, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
20:53, September 29, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Trends and Forces)
14:37, September 25, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo's Drug Portfolio Is Not Diverse and Faces Generic Competition)
12:40, September 25, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Trends and Forces)
11:56, September 25, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Capital for Clinical Trials and Acquisitions)
11:52, September 25, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Capital for Clinical Trials and Acquisitions)
12:50, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
12:50, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Liquid Capital for Clinical Trials and Acquisitions)
12:49, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Liquid Capital for Clinical Trials and Acquisitions)
12:47, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Liquid Capital for Clinical Trials and Acquisitions)
12:45, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo's Drug Portfolio Is Not Diverse and Faces Generic Competition)
12:44, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Is Being Investigated for "Off-Label" Prescription of Lidoderm)
12:44, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Is Being Investigated for "Off-Label" Prescription of Lidoderm)
12:43, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo's Drug Portfolio Is Not Diverse and Faces Generic Competition)
12:42, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Market Conditions Have Constrained Endo's Access to Liquid Capital for Clinical Trials and Acquisitions)
12:40, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
12:22, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
12:21, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
12:08, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
12:06, September 23, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo's Cash Flow for Clinical Trials and Acquisitions Is Drying Up Due to Market Conditions)
12:00, September 23, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
11:32, September 21, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
10:50, September 21, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
13:01, September 18, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)
12:55, September 18, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
12:18, September 18, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
12:16, September 18, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)
12:16, September 18, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP)
17:52, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP)
17:39, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)
17:38, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)
17:29, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
17:28, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
17:23, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
17:22, September 16, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Oxymorphone Brands)
17:21, September 16, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Oxymorphone Brands)
17:16, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Competition)
17:15, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Competition)
17:09, September 16, 2008(hist)(diff)Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
17:07, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)
17:03, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Faces Potential Competition from Generics of its Own Products)
17:03, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Faces Potential Competition from Generics of its Own Products)
16:56, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo is Highly Profitable, but Undiversified and Facing Future Cash Flow Problems)
16:45, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
16:39, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Company Overview)
16:35, September 16, 2008(hist)(diff)m Stock:Endo Pharmaceuticals Holdings (ENDP) (→Endo Must Contend with Legal Action and Clinical Trial Uncertainties)

(Newest | Oldest) View (Newer 50) (Older 50)

Retrieved from "http://www.wikinvest.com/special/Contributions"
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki